New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Eton Pharmaceuticals, Inc.
https://etonpharma.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Eton Pharmaceuticals, Inc.
Keeping Track: Kadmon Chooses RTOR For Belumosudil; NDAs For Novel Imaging Agents And Liquid Anticonvulsants
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Keeping Track: Disappointment For Mesoblast And Aquestive; Opdivo/Yervoy Add Mesothelioma Claim; Pediatric Approvals
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Major Milestone For Diurnal As FDA Approves Alkindi
The US green light for Alkindi is a big step for the UK biotech in its bid to become a world-leading specialty endocrinology business.
US FDA Approval Activity Could Cool Down In September
With just 10 user fee goal dates coming up, September could be break from the fast pace of FDA decisions over the summer.
Company Information
- Industry
-
Pharmaceuticals
- Specialty Pharmaceuticals